Pfizer registers Phase 3 marstacimab hemophilia trial and elranatamab myeloma comparison studyNov 12Weekly roundup, 10 itemsabrocitinibberobenatide
Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Pfizer wins two FDA labeling supplements; obesity trial roster unchangedOct 15Weekly roundup, 8 itemsberobenatidemethotrexate
Pfizer's Ruxience biosimilar supplement approved; breast cancer trials post resultsSep 30Weekly roundup, 8 itemsatirmociclibberobenatideUpdated
Pfizer wins Xeljanz label update; registers four new trials across RSV, eczema, sleep apneaSep 16Weekly roundup, 7 itemsabrocitinibberobenatide
CIBINQO label updated by FDA; Pfizer's rimegepant China trial and pipeline items still activeSep 3Weekly roundup, 7 itemsabrocitinibberobenatide
Pfizer posts MET097 obesity results; registers new Phase 3 obesity and dermatitis trialsAug 28Weekly roundup, 6 itemsberobenatidePF-08154225